|
WO2010029579A2
|
|
Non-aqueous solution process for the preparation of cross-linked polymers
|
|
WO2011001228A1
|
|
Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
|
|
WO2009084041A2
|
|
Pharmaceutical compositions of dexibuprofen
|
|
WO2006072966A1
|
|
High-bulk density carisoprodol suitable for direct compression
|
|
US2008234479A1
|
|
Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
|
|
EP1781666A1
|
|
Improved process for making form i of olanzapine.
|
|
WO2005005437A1
|
|
An improved process for the manufacture of isradipine.
|
|
AU2003269482A1
|
|
Process for the manufacture of 2,1,3-benzoxadiazole-4-carboxaldehyde
|
|
AU2003263582A1
|
|
Process for the manufacture of rofecoxib
|
|
AU2003259544A1
|
|
Process for the preparation of gabapentin
|
|
WO2004087932A2
|
|
Enzymatic resolution of (±) methyl trans-3-phenyl glycidate
|
|
AU2003253250A8
|
|
Enzymatic resolution of (plus or minus) methyl trans-3-phenyl glycidate
|
|
AU2002246303A1
|
|
Preparation of new mineral acid addition salts of gabapentin
|
|
AU2002214243A1
|
|
1-((4-methyl thio)phenyl)-2-(phenyl acetoxy)-1-ethanone and a process for preparing the same
|
